These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10220313)

  • 21. Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli.
    Kim DH; Kim KH; Isin EM; Guengerich FP; Chae HZ; Ahn T; Yun CH
    Protein Expr Purif; 2008 Feb; 57(2):188-200. PubMed ID: 18032064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.
    Murayama N; Soyama A; Saito Y; Nakajima Y; Komamura K; Ueno K; Kamakura S; Kitakaze M; Kimura H; Goto Y; Saitoh O; Katoh M; Ohnuma T; Kawai M; Sugai K; Ohtsuki T; Suzuki C; Minami N; Ozawa S; Sawada J
    J Pharmacol Exp Ther; 2004 Jan; 308(1):300-6. PubMed ID: 14563787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of MeIQ (2-amino-3,4-dimethylimidazo- [4,5-f]quinoline) by sequence variants of recombinant human cytochrome P450 1A2.
    Josephy PD; Bibeau KL; Evans DH
    Environ Mol Mutagen; 2000; 35(4):328-35. PubMed ID: 10861951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a fusion protein between human cytochrome P450 1A1 and rat NADPH-P450 oxidoreductase in Escherichia coli.
    Chun YJ; Jeong TC; Roh JK; Guengerich FP
    Biochem Biophys Res Commun; 1997 Jan; 230(1):211-4. PubMed ID: 9020048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering of pyridine nucleotide specificity of nitrate reductase: mutagenesis of recombinant cytochrome b reductase fragment of Neurospora crassa NADPH:Nitrate reductase.
    Shiraishi N; Croy C; Kaur J; Campbell WH
    Arch Biochem Biophys; 1998 Oct; 358(1):104-15. PubMed ID: 9750171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines.
    Suzuki A; Kushida H; Iwata H; Watanabe M; Nohmi T; Fujita K; Gonzalez FJ; Kamataki T
    Cancer Res; 1998 May; 58(9):1833-8. PubMed ID: 9581821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
    Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
    FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines.
    Schmalix WA; Lang D; Schneider A; Bocker R; Greim H; Doehmer J
    Drug Metab Dispos; 1996 Dec; 24(12):1314-9. PubMed ID: 8971136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Libraries of hybrid proteins from distantly related sequences.
    Sieber V; Martinez CA; Arnold FH
    Nat Biotechnol; 2001 May; 19(5):456-60. PubMed ID: 11329016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidations of p-alkoxyacylanilides catalyzed by human cytochrome P450 1A2: structure-activity relationships and simulation of rate constants of individual steps in catalysis.
    Yun CH; Miller GP; Guengerich FP
    Biochemistry; 2001 Apr; 40(14):4521-30. PubMed ID: 11284709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-directed mutagenesis of the putative distal helix of peroxygenase cytochrome P450.
    Matsunaga I; Ueda A; Sumimoto T; Ichihara K; Ayata M; Ogura H
    Arch Biochem Biophys; 2001 Oct; 394(1):45-53. PubMed ID: 11566026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization of four allelic variants of human cytochrome P450 1A2.
    Zhou H; Josephy PD; Kim D; Guengerich FP
    Arch Biochem Biophys; 2004 Feb; 422(1):23-30. PubMed ID: 14725854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype.
    Guengerich FP; Parikh A; Turesky RJ; Josephy PD
    Mutat Res; 1999 Jul; 428(1-2):115-24. PubMed ID: 10517985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High yield purification and characterization of engineered human P450 1A2 and generation of immuno-inhibitor antibodies.
    Louërat-Oriou B; Flinois JP; Beaune PH; Pompon D
    Pharmacogenetics; 1999 Feb; 9(1):61-70. PubMed ID: 10208644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrostatic interaction between cytochrome P450 and NADPH-P450 reductase: comparison of mixed and fused systems consisting of rat cytochrome P450 1A1 and yeast NADPH-P450 reductase.
    Kondo S; Sakaki T; Ohkawa H; Inouye K
    Biochem Biophys Res Commun; 1999 Apr; 257(2):273-8. PubMed ID: 10198202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants.
    Lussenburg BM; Babel LC; Vermeulen NP; Commandeur JN
    Anal Biochem; 2005 Jun; 341(1):148-55. PubMed ID: 15866539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Kang IH; Kim HJ; Oh H; Park YI; Dong MS
    Mutat Res; 2004 Jan; 545(1-2):37-47. PubMed ID: 14698415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants.
    Tu Y; Deshmukh R; Sivaneri M; Szklarz GD
    Drug Metab Dispos; 2008 Nov; 36(11):2371-80. PubMed ID: 18703643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
    Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
    Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of LYS271 and LYS279 residues in the interaction of cytochrome P4501A1 with NADPH-cytochrome P450 reductase.
    Cvrk T; Strobel HW
    Arch Biochem Biophys; 2001 Jan; 385(2):290-300. PubMed ID: 11368010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.